Skip to main content

What clinicians need to know

The standard contains eight quality statements to ensure that people with osteoarthritis of the knee receive timely assessment and optimal management, to enhance quality of life and lessen the disability caused by knee osteoarthritis.

What is knee osteoarthritis?

2024
Publication, report or update

This bimonthly update provides data submitted to CARAlert for the reporting period 1 March to 30 April 2024. These data can be used to support the prevention and control of antimicrobial resistance.

2024
Newsletter

This issue includes items on prevention, oral health, medication safety, patient engagement, COVID-19, and more. Also covered are the latest from Australian Prescriber, BMJ Quality & Safety, Pediatric Quality & Safety, Public Health Research & Practice and International Journal for Quality in Health Care.

Read the latest edition of Person-centred Care Insights.

2024
Newsletter

Read the latest edition of Person-centred Care Insights. Dive into person-centred care! Browse innovative projects from our network. Find new resources, tools, training opportunities, upcoming events, and the latest publications on person-centred care.

2024
Publication, report or update

This Communiqué provides an update on the second meeting of the National Sepsis Oversight Group (Oversight Group). It may be used by members to update their nominating organisations and other key agencies about the National Sepsis Program Extension (Program Extension).

This advisory describes the minimum requirements for Action 5.13 for health service organisations establishing a comprehensive plan.

2024
Newsletter

This issue includes items on newly released Women's Health Focus Report and revised Heavy Menstrual Bleeding Clinical Care Standard, the updated High Risk Medicines eLearning module, the Global Patient Safety Report 2024, design creativity in healthcare improvement, mental health, healthcare safety, hospital acquired complications (HACs), stakeholder engagement, falls, aged care, COVID-19, and more.

Back to top